ArticleScientific reports2025
The combined associations of excess body weight, hypertension, and hypertriglyceridemia with hyperglycemia among nondiabetic older adults in regional China.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
To investigate the separate and combined associations of excess body weight (EBW), hypertension (HTN), and hypertriglyceridemia (HTG) with hyperglycemia among non-diabetic adults aged 60 years and above in regional China. In this cross-sectional study conducted in 2023, 26,769 non-diabetic individuals aged 60 years and older were selected from Nanjing municipality, China. Body weight and height, blood pressure, fasting plasma triglycerides, and glucose were objectively measured, while socio-demographic attributes, lifestyle and behaviors, and disease history were self-reported. The outcome variable was hyperglycemia. Independent variables included EBW, HTN, HTG, and their combinations. Mixed-effects logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) to assess the separate and combined associations of EBW, HTN, and HTG with hyperglycemia. Among all participants, the prevalence of hyperglycemia was 16.3%, while 14.0%, 57.2%, and 27.8% had obesity, HTN, and HTG, respectively. After adjusting for potential confounders, individuals with EBW, HTN, or HTG were independently more likely to experience hyperglycemia compared to those without the corresponding condition. Participants with any two-factor combinations of these three conditions had a higher risk of hyperglycemia than those with only one. Moreover, individuals with the three conditions had substantially greater odds of hyperglycemia than those with any two-factor combinations. Obese adults with both HTN and HTG had 5.04-fold higher odds (95%CI = 4.31, 5.90), while overweight individuals with HTN and HTG had 3.20-fold higher odds (95%CI = 2.79, 3.67) of experiencing hyperglycemia, compared to those with normal body weight, blood pressure, and triglyceride levels. Among men, individuals with obesity who had HTN and HTG had 5.15-fold higher odds (95%CI = 4.02, 6.61), and overweight individuals with HTN and HTG had 3.27-fold higher odds (95%CI = 2.63, 4.05). Among women, individuals with obesity who had HTN and HTG had 5.36-fold higher odds (95%CI = 4.22, 6.82), and overweight individuals with HTN and HTG had 3.40-fold higher odds (95%CI = 2.74, 4.22) of hyperglycemia. EBW, HTN, and HTG jointly increased the risk of hyperglycemia among older adults, both men and women, aged 60 years and above in China. These findings have important public health implications, suggesting that personalized interventions targeting EBW, HTN, and HTG may serve as an effective strategy for the population-level prevention of hyperglycemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.